Photocure ASA

OVERVIEW |  NEWS |  MULTIMEDIA  | RESEARCH

---

Photocure ASA Company Summary

COMPANY DATA

	Homepage	www.photocure.com

---

Key Developments: Photocure ASA

	Photocure ASA (OSL:PHO) Photocure's Cevira(TM) Shows Positive Interim Results For Treatment Of Precancerous Lesions Of The Cervix NOV 17, 2008 17:03 - Article Views: 442 Photocure ASA (OSL:PHO) Six-month interim data presented at international conference addressing prevention of cervical cancer
	Photocure ASA (OSL:PHO) Third Quarter Report 2008 OCT 24, 2008 17:07 - Article Views: 240 Photocure ASA (OSL:PHO) Oslo, Norway, October 24th 2008.
	Photocure ASA (OSL:PHO) PRESENTATION OF THE 3RD QUARTER 2008 REPORT OCT 20, 2008 21:45 - Article Views: 302 Photocure ASA (OSL:PHO) Photocure ASA will present its third quarter 2008 report on Friday 24th of October 2008 at Shippingklubben, Haakon VIIs gate 1 (top floor), Oslo, Norway. The presentation will begin at 08.15 (CET) and representatives from the company will be Kjetil Hestdal, President & CEO and Christian Fekete, CFO.
	Photocure ASA (OSL:PHO) Phase III Study Results Demonstrate That Hexvix Cystoscopy Leads To Significantly Improved Patient Outcome SEP 12, 2008 16:03 - Article Views: 384 Photocure ASA (OSL:PHO) New data confirms benefits of Hexvix cystoscopy and will form key part of documentation towards gaining regulatory approval in the USA
	Photocure ASA (OSL:PHO) Photocure's Newly Developed Aktilite® CL512 Lamp Has Received CE Mark SEP 9, 2008 16:21 - Article Views: 1,396 Photocure ASA (OSL:PHO) Oslo, Norway, 9 September 2008 - Photocure's newly developed third-generation lamp, Aktilite CL512, for use in photodynamic therapy (PDT), has received a CE mark and is now certified by Nemko, the official Notified Body within EU/EEA for medical devices.
	Photocure ASA (OSL:PHO) National Health Service (NHS) In UK Commits To Adopting Photodynamic Diagnosis Of Bladder Cancer As A Standard Procedure SEP 8, 2008 16:03 - Article Views: 355 Photocure ASA (OSL:PHO) Oslo, Norway, 8 September 2008 - Photocure is very pleased to note the recent press release by GE Healthcare (please see attachment) on the decision by the UK National Health Service (NHS) to commit to a programme designed to promote the adoption of photodynamic diagnosis (PDD) of bladder cancer as standard care.
	Photocure ASA (OSL:PHO) Postive Phase II Results With VisonacTM For Acne AUG 27, 2008 16:19 - Article Views: 285 Photocure ASA (OSL:PHO) Studies demonstrate efficacy and safety of VisonacTM and the potential for a simplified Photodynamic Therapy (PDT) procedure for treatment of moderate to severe acne.
	Photocure ASA (OSL:PHO) Metvix® Prevents Pre-cancerous Lesions In Transplant Patients AUG 21, 2008 16:59 - Article Views: 189 Photocure ASA (OSL:PHO) Oslo, Norway, 21 August, 2008.
	Photocure ASA (OSL:PHO) Second Quarter/First Half Report 2008 AUG 15, 2008 16:07 - Article Views: 192 Photocure ASA (OSL:PHO) Oslo, Norway, August 15th 2008.
	PRESENTATION OF THE 2ND QUARTER 2008 REPORT AUG 12, 2008 21:33 - Article Views: 266 Photocure ASA (OSL:PHO) Photocure ASA will present its second quarter 2008 report on Friday 15th of August 2008 at Shippingklubben, Haakon VIIs gate 1 (top floor), Oslo, Norway. The presentation will begin at 08.15 (CET) and representatives from the company will be Kjetil Hestdal, President & CEO and Christian Fekete, CFO.

129 COMPANY PROFILE VIEWS

This Page Viewed: (Last 7 Days: 3) (Last 30 Days: 16) (Since Published: 129)